Mechanisms of the antidiabetic effects of the β3-adrenergic agonist CL-316243 in obese Zucker-ZDF rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 274, Issue 5 43-5, 1998, Pages

  Liu, Xilin ^a   Pérusse, Fleurette ^a   Bukowiecki, Ludwik J ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

Brown adipose tissue; Diabetes; Insulin; Obesity; Skeletal muscles

Indexed keywords

5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; ANTIDIABETIC AGENT; CYTOCHROME C OXIDASE; DEOXYGLUCOSE; FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BROWN ADIPOSE TISSUE; COLD EXPOSURE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORT; INSULIN RESPONSE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; WHITE ADIPOSE TISSUE;

EID: 0031802989     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1998.274.5.r1212     Document Type: Article

References (56)

1. 3-adrenergic receptor agonists in obese mice. Am. J. Physiol. 268 (Endocrinol. Metab. 31): E678-E684, 1995.
2. Arch, J. R. S., A. T. Ainsworth, M. A. Cawthorne, V. Piercy, M. V. Sennitt, V. E. Thody, C. Wilson, and S. Wilson. Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature 309: 163-165, 1984.
3. 3-adrenoceptors in the regulation of lipolysis and thermogenesis in rat brown adipocytes. Am. J. Physiol. 273 (Cell Physiol. 42): C1136-C1142, 1997.
4. Atgié, C., A. Marette, M. Desautels, O. Tulp, and L. J. Bukowiecki. Specific decrease of mitochondrial thermogenic capacity in brown adipose tissue of obese SHR/N-cp rats. Am. J. Physiol. 265 (Cell Physiol. 34): C1674-C1680, 1993.
5. 3-Adrenoceptor in guinea pig brown and white adipocytes: low expression and lack of function. Am. J. Physiol. 271 (Regulatory Integrative Comp. Physiol. 40): R1729-R1738, 1996.
6. Atkinson, R. L., R. C. Blank, J. F. Loper, D. Schumacher, and R. A. Lutes. Combined drug treatment of obesity. Obesity Res. 3, Suppl. 4: 497S-500S, 1995.
7. Bloom, J. D., M. D. Dutia, B. D. Johnson, A. Wissner, M. G. Burns, E. E. Largis, J. A. Dolan, and T. H. Claus. Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino] propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent beta-adrenergic agonist virtually specific for beta 3 receptors. A promising antidiabetic and antiobesity agent. J. Med. Chem. 35: 3081-3084, 1992.
8. Boss, O., S. Samec, A. PaoloniGiacobino, C. Rossier, A. Dulloo, J. Seydoux, P. Muzzin, and J. Giacobino. Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue-specific expression. FEBS Lett. 408: 39-42, 1997.
9. Carpéné, C., J. Galitzky, P. Collon, F. Esclapez, M. Dauzats, and M. Lafontan. Desensitization of beta-1 and beta-2, but not beta-3, adrenoceptor-mediated lipolytic responses of adipocytes after long-term norepinephrine infusion. J. Pharmacol. Exp. Ther. 265: 237-247, 1993.
10. 3-adrenoceptors in intact brown adipocytes of the rat. Br. J. Pharmacol. 114: 275-282, 1995.
11. D'Allaire, F., X. Liu, F. Pérusse, and L. J. Bukowiecki. Mechanisms of the beneficial effects of the selective β3-agonist CL 316 243 on obesity, diabetes and energy expenditure (Abstract). Obesity Res. 4, Suppl. 1: 16S, 1996.
12. Dulloo, A. G., J. B. Young, and L. Landsberg. Sympathetic nervous system responses to cold exposure and diet in rat skeletal muscle. Am. J. Physiol. 255 (Endocrinol. Metab. 18): E180-E188, 1988.
13. Fleury, C., M. Neverova, S. Collins, S. Raimbault, O. Champigny, C. Levi-Meyrueis, F. Bouillaud, M. Seldin, R. Surwit, D. Ricquier, and C. Warden. Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat. Genet. 15: 269-272, 1997.
14. Friedman, J. E., J. E. De Vente, R. G. Peterson, and G. L. Dohm. Altered expression of muscle glucose transporter GLUT-4 in diabetic fatty Zucker rats (ZDF/Drt-fa). Am. J. Physiol. 261 (Endocrinol. Metab. 24): E782-E788, 1991.
15. Gauthier, C., G. Tavernier, F. Charpentier, D. Langin, and H. Le Marec. Functional beta3-adrenoceptor in the human heart. J. Clin. Invest. 98: 556-562, 1996.
16. Géloën, A., A. J. Collet, G. Guay, and L. J. Bukowiecki. In vivo differentiation of brown adipocytes in adult mice: an electron microscopic study. Am. J. Anat. 188: 366-372, 1990.
17. Géloën, A., A. J. Collet, G. Guay, and L. J. Bukowiecki. β-Adrenergic stimulation of brown adipocyte proliferation. Am. J. Physiol. 254 (Cell Physiol. 23): C175-C182, 1988.
18. Ghorbani, M., T. Claus, and J. Himms-Hagen. Hypertrophy of brown adipocytes in brown and white adipose tissues and reversal of diet-induced obesity in rats treated with a beta(3)-adrenoceptor agonist. Biochem. Pharmacol. 54: 121-131, 1997.
19. Ghorbani, M., and J. Himms-Hagen. Appearance of brown adipocytes in white adipose tissue during CL 316,243-induced reversal of obesity and diabetes in Zucker fa/fa rats. Int. J. Obes. 21: 465-475, 1997.
20. Gimeno, R., M. Dembski, X. Weng, N. Deng, A. Shyjan, C. Gimeno, F. Iris, S. Ellis, E. Woolf, and L. Tartaglia. Cloning and characterization of an uncoupling protein homolog: a potential molecular mediator of human thermogenesis. Diabetes 46: 900-906, 1997.
21. Goglia, F., A. Géloën, C. Atgié, A. Marette, and L. J. Bukowiecki. Morphometric-stereologic analysis of brown adipocytes in lean and obese SHR/N-cp rats (Abstract). Int. J. Obes. 7, Suppl. 2: 10, 1993.
22. Goglia, F., A. Géloën, A. Lanni, Y. Minaire, and L. J. Bukowiecki. Morphometric-stereologic analysis of brown adipocyte differentiation in adult mice. Am. J. Physiol. 262 (Cell Physiol. 31): C1018-C1023, 1992.
23. 3-adrenergic receptors to adenylyl cyclase in isolated adipocytes. J. Pharmacol. Exp. Ther. 261: 638-642, 1992.
24. Himms-Hagen, J. Brown adipose tissue thermogenesis: role in thermoregulation, energy regulation and obesity. In: Thermoregulation: Physiology and Biochemistry, edited by E. Schönbaum and P. Lomax. New York: Pergamon, 1990, p. 327-341.
25. Himms-Hagen, J. Neural control of brown adipose tissue thermogenesis, hypertrophy, and atrophy. In: Frontiers in Neuroendocrinology, edited by W. F. Ganong and L. Martini. New York: Raven, 1991, p. 38-91.
26. 3 agonist, on energy balance and brown and white adipose tissues in rats. Am. J. Physiol. 266 (Regulatory Integrative Comp. Physiol. 35): R1371-R1382, 1994.
27. Kaumann, A. J. Four β-adrenoceptor subtypes in the mammalian heart. Trends Pharmacol. Sci. 18: 70-76, 1997.
28. Kraegen, E. W., D. E. James, A. B. Jenkins, and D. J. Chisholm. Dose-response curves for in vivo insulin sensitivity in individual tissues in rats. Am. J. Physiol. 248 (Endocrinol. Metab. 11): E353-E362, 1985.
29. Kraegen, E. W., D. E. James, L. H. Storlien, K. M. Burleigh, and D. J. Chisholm. In vivo insulin resistance in individual peripheral tissues of the high fat fed rat: assessment by euglycaemic clamp plus deoxyglucose administration. Diabetologia 29: 192-198, 1986.
30. Lafontan, M., and M. Berlan. Fat cell adrenergic receptors and the control of white and brown fat cell function. Rev. J. Lipid. Res. 34: 1057-1091, 1993.
31. Landsberg, L., M. E. Saville, and J. B. Young. Sympathoadrenal system and regulation of thermogenesis. Am. J. Physiol. 247 (Endocrinol. Metab. 10): E181-E189, 1984.
32. 3-adrenoceptors. Br. J. Clin. Pharmacol. 42: 291-300, 1996.
33. Liu, X., F. Pérusse, and L. J. Bukowiecki. Chronic norepinephrine infusion stimulates glucose uptake in white and brown adipose tissues. Am. J. Physiol. 266 (Regulatory Integrative Comp. Physiol. 35): R914-R920, 1994.
34. Liu, Y.-L., M. A. Cawthorne, and M. J. Stock. Biphasic effects of the β-adrenoceptor agonist, BRL 37344, on glucose utilization in rat isolated skeletal muscle. Br. J. Pharmacol. 117: 1355-1361, 1996.
35. Marette, A., and L. J. Bukowiecki. Noradrenaline stimulates glucose transport in rat brown adipocytes by activating thermogenesis. Biochem. J. 277: 119-124, 1991.
36. Marette, A., Y. Deshaies, A. J. Collet, O. Tulp, and L. J. Bukowiecki. Major thermogenic defect associated with insulin resistance in brown adipose tissue of obese diabetic SHR/N-cp rats. Am. J. Physiol. 261 (Endocrinol. Metab. 24): E204-E213, 1991.
37. Marette, A., P. Mauriège, J.-P. Després, O. L. Tulp, and L. J. Bukowiecki. Norepinephrine- and insulin-resistant glucose transport in brown adipocytes from diabetic SHR/N-cp rats. Am. J. Physiol. 265 (Regulatory Integrative Comp. Physiol. 34): R577-R583, 1993.
38. 3-adrenergic agonist. J. Clin. Invest. 97: 2898-2904, 1996.
39. Nantel, F., H. Bonin, L. J. Emorine, V. Zilberfarb, A. D. Strosberg, M. Bouvier, and S. Marullo. The human beta3-adrenergic receptor is resistant to short term agonist-promoted desensitization. Mol. Pharmacol. 43: 548-555, 1993.
40. 3-adrenergic receptor. J. Biol. Chem. 269: 13148-13155, 1994.
41. Peterson, R. G., W. N. Shaw, M.-A. Neel, L. A. Little, and J. Eichberg. Zucker diabetic fatty rat as a model for non-insulin-dependent diabetes mellitus. (Abstract). Institute of Laboratory Animal Resources News 32: 16-19, 1990.
42. Randle, P. J., P. Garland, C. N. Hales, and E. A. Newsholme. The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1: 785-789, 1963.
43. Shibata, H., and L. J. Bukowiecki. Regulatory alterations of daily energy expenditure induced by fasting and overfeeding in unrestrained rats. J. Appl. Physiol. 63: 465-470, 1987.
44. Shibata, H., F. Pérusse, A. Vallerand, and L. J. Bukowiecki. Cold exposure reverses inhibitory effects of fasting on peripheral glucose uptake in rats. Am. J. Physiol. 257 (Regulatory Integrative Comp. Physiol. 26): R96-R101, 1989.
45. Shiota, M., and S. Masumi. Effect of norepinephrine on consumption of oxygen in perfused skeletal muscle from cold-exposed rats. Am. J. Physiol. 254 (Endocrinol. Metab. 17): E482-E489, 1988.
46. Simard, P.-M., C. Atgié, P. Mauriège, F. D'Allaire, and L. J. Bukowiecki. Comparison of the lipolytic effects of norepinephrine and BRL 37344 in rat brown and white adipocytes. Obesity Res. 2: 424-431, 1994.
47. vy/a). Diabetes 41: 187-193, 1992.
48. Smith, S. A., M. V. Sennitt, and M. A. Cawthorne. BRL 35135: an orally active anti-hyperglycemic agent with weight reducing effects. In: New Anti-Diabetic Drugs, edited by C. J. Bailey and P. R. Flatt. London: Smith-Gordon, 1990, p. 177-189.
49. Sreenan, S., J. Sturis, W. Pugh, C. F. Burant, and K. S. Polonsky. Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment with metformin or troglitazone. Am. J. Physiol. 271 (Endocrinol. Metab. 34): E742-E747, 1996.
50. 3-adrenergic receptor gene. J. Biol. Chem. 270: 29483-29492, 1995.
51. Takahashi, A., M. Sudo, Y. Minokoshi, and T. Shimazu. Effects of ventromedial hypothalamic stimulation on glucose transport system in rat tissues. Am. J. Physiol. 263 (Regulatory Integrative Comp. Physiol. 32): R1228-R1234, 1992.
52. Vallerand, A. L., J. Lupien, and L. J. Bukowiecki. Cold exposure reverses the diabetogenic effect of high-fat feeding. Diabetes 35: 329-334, 1986.
53. Vallerand, A. L., J. Lupien, and L. J. Bukowiecki. Interactions of cold exposure and starvation on glucose tolerance and insulin response. Am. J. Physiol. 245 (Endocrinol. Metab. 8): E575-E581, 1983.
54. Vallerand, A. L., F. Pérusse, and L. J. Bukowiecki. Cold exposure potentiates the effect of insulin on in vivo glucose uptake. Am. J. Physiol. 253 (Endocrinol. Metab. 16): E179-E186, 1987.
55. Vallerand, A. L., F. Pérusse, and L. J. Bukowiecki. Stimulatory effects of cold exposure and cold acclimation on glucose uptake in rat peripheral tissues. Am. J. Physiol. 259 (Regulatory Integrative Comp. Physiol. 28): R1043-R1049, 1990.
56. VidalPuig, A., G. Solanes, D. Grujic, J. Flier, and B. Lowell. UCP3: an uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue. Biochem. Biophys. Res. Commun. 235: 79-82, 1997.